
Danaher (DHR) Stock Forecast & Price Target
Danaher (DHR) Analyst Ratings
Bulls say
Danaher is a global manufacturing company, primarily focused on producing scientific instruments and consumables for the life sciences and diagnostic industries. With a culture of continuous improvement and a solid track record of organic growth and strategic acquisitions, Danaher has consistently expanded its market share and revenue. Despite some short-term headwinds, such as a seasonal decline in respiratory testing, Danaher's diversified portfolio and strong leadership position in key markets make it a solid investment opportunity for long-term growth.
Bears say
Danaher is facing declining sales in its Life Sciences division and specifically in instrument demand, showing a trend likely to continue due to market uncertainty and biotech funding recovery lag. While the company prioritizes sustainability and has a diverse leadership team, its global manufacturing footprint and potential for high growth end-markets not recovering pose risks. The recent 2Q26 guidance expects core revenue growth in low single digits due to various factors such as geopolitical and macro headwinds, with risks including geopolitical disruptions and changes to forecasted end-market growth rates.
This aggregate rating is based on analysts' research of Danaher and is not a guaranteed prediction by Public.com or investment advice.
Danaher (DHR) Analyst Forecast & Price Prediction
Start investing in Danaher (DHR)
Order type
Buy in
Order amount
Est. shares
0 shares